Search research articles
Contact Us
Filters
Showing results (71-80 of 419) with videos related to
Page
of 42
Sort By:
Frontiers in Microbiology
|
June 18, 2024
Longitudinal molecular analysis of clinical and fecal <i>Escherichia coli</i> isolates at a Veterans Affairs Medical Center in Minnesota, USA, 2012-2019
Connie Clabots, Paul Thuras, James R Johnson
JAMA
|
November 23, 2021
Effect of 7 vs 14 Days of Antibiotics Among Afebrile Men With Urinary Tract Infection-Reply
Dimitri M Drekonja, Barbara Trautner, James R Johnson
Microbiology (Reading, England)
|
May 4, 2002
The genetic structure of Escherichia coli populations in primary and secondary habitats
David M Gordon, Sonja Bauer, James R Johnson
Microbiology (Reading, England)
|
March 27, 2025
Phylogenetic groups and extraintestinal virulence genes of inflow <i>Escherichia coli</i> entering a municipal drinking water treatment facility (St. Paul, MN, USA)
James R Johnson, Brian D Johnston, Paul Thuras
Antimicrobial Agents and Chemotherapy
|
July 4, 2012
In vitro comparison of nitrofurazone- and silver alloy-coated foley catheters for contact-dependent and diffusible inhibition of urinary tract infection-associated microorganisms
James R Johnson, Brian Johnston, Michael A Kuskowski
JAMA Internal Medicine
|
December 6, 2012
Preoperative urine cultures at a veterans affairs medical center
Dimitri M Drekonja, Breanna Zarmbinski, James R Johnson
Infection Control and Hospital Epidemiology
|
April 16, 2019
Predictive characteristics of methicillin-resistant Staphylococcus aureus nares screening tests for methicillin resistance among S. aureus clinical isolates from hospitalized veterans
Teresa C Fox, Paul Thuras, James R Johnson
Plos One
|
July 11, 2018
Activity of ceftolozane-tazobactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status
Brian D Johnston, Paul Thuras, James R Johnson
The Journal of Infectious Diseases
|
November 14, 2015
Important Complexities of the Antivirulence Target Paradigm: A Novel Ostensibly Resistance-Avoiding Approach for Treating Infections
Thomas A Russo, Brad Spellberg, James R Johnson
Bioconjugate Chemistry
|
April 11, 2008
Zinc(II)-coordinated oligotyrosine: a new class of cell penetrating peptide
James R Johnson, Hua Jiang, Bradley D Smith
Page
of 42
Search research articles
Search
Showing results (71-80 of 419) with videos related to
Sort By:
Page
of 42
Frontiers in Microbiology
|
June 18, 2024
Longitudinal molecular analysis of clinical and fecal <i>Escherichia coli</i> isolates at a Veterans Affairs Medical Center in Minnesota, USA, 2012-2019
Connie Clabots, Paul Thuras, James R Johnson
JAMA
|
November 23, 2021
Effect of 7 vs 14 Days of Antibiotics Among Afebrile Men With Urinary Tract Infection-Reply
Dimitri M Drekonja, Barbara Trautner, James R Johnson
Microbiology (Reading, England)
|
May 4, 2002
The genetic structure of Escherichia coli populations in primary and secondary habitats
David M Gordon, Sonja Bauer, James R Johnson
Microbiology (Reading, England)
|
March 27, 2025
Phylogenetic groups and extraintestinal virulence genes of inflow <i>Escherichia coli</i> entering a municipal drinking water treatment facility (St. Paul, MN, USA)
James R Johnson, Brian D Johnston, Paul Thuras
Antimicrobial Agents and Chemotherapy
|
July 4, 2012
In vitro comparison of nitrofurazone- and silver alloy-coated foley catheters for contact-dependent and diffusible inhibition of urinary tract infection-associated microorganisms
James R Johnson, Brian Johnston, Michael A Kuskowski
JAMA Internal Medicine
|
December 6, 2012
Preoperative urine cultures at a veterans affairs medical center
Dimitri M Drekonja, Breanna Zarmbinski, James R Johnson
Infection Control and Hospital Epidemiology
|
April 16, 2019
Predictive characteristics of methicillin-resistant Staphylococcus aureus nares screening tests for methicillin resistance among S. aureus clinical isolates from hospitalized veterans
Teresa C Fox, Paul Thuras, James R Johnson
Plos One
|
July 11, 2018
Activity of ceftolozane-tazobactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status
Brian D Johnston, Paul Thuras, James R Johnson
The Journal of Infectious Diseases
|
November 14, 2015
Important Complexities of the Antivirulence Target Paradigm: A Novel Ostensibly Resistance-Avoiding Approach for Treating Infections
Thomas A Russo, Brad Spellberg, James R Johnson
Bioconjugate Chemistry
|
April 11, 2008
Zinc(II)-coordinated oligotyrosine: a new class of cell penetrating peptide
James R Johnson, Hua Jiang, Bradley D Smith
Page
of 42